Literature DB >> 1372732

The influence of sucrose, dextran, and hydroxypropyl-beta-cyclodextrin as lyoprotectants for a freeze-dried mouse IgG2a monoclonal antibody (MN12).

M E Ressing1, W Jiskoot, H Talsma, C W van Ingen, E C Beuvery, D J Crommelin.   

Abstract

The influence of lyophilization on the stability of a monoclonal antibody (MN12) was investigated. MN12 was freeze-dried in different formulations [without lyoprotectant or in the presence of sucrose, dextran, or hydroxypropyl-beta-cyclodextrin (HP beta CD)] and under varying conditions (with or without secondary drying). Subsequently, the monoclonal antibody was stored for 18 or 32 days at various temperatures (4, 37, or 56 degrees C). For comparison, solutions of MN12 were stored under the same conditions. Regardless of the lyoprotectant used, precipitation and a concomitant reduction of the antigen-binding capacity by about 10% were observed upon reconstitution of lyophilized MN12. HP beta CD proved to be the most effective stabilizer to prevent degradation of lyophilized MN12 during storage. Compared with MN12 solutions, HP beta CD-containing lyophilized MN12 cakes were more resistant to heat-induced charge alterations and loss of antigen-binding capacity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372732     DOI: 10.1023/a:1018905927544

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  Nature of aggregates formed during storage of freeze-dried ribonuclease A.

Authors:  M W Townsend; P P DeLuca
Journal:  J Pharm Sci       Date:  1991-01       Impact factor: 3.534

2.  Preparation of clinical grade monoclonal antibodies from serum-containing cell culture supernatants.

Authors:  W Jiskoot; J J Van Hertrooij; A M Hoven; J W Klein Gebbinck; T Van der Velden-de Groot; D J Crommelin; E C Beuvery
Journal:  J Immunol Methods       Date:  1991-04-25       Impact factor: 2.303

3.  The effects of formulation additives on the degradation of freeze-dried ribonuclease A.

Authors:  M W Townsend; P R Byron; P P DeLuca
Journal:  Pharm Res       Date:  1990-10       Impact factor: 4.200

4.  Factors influencing changes in moisture content during storage of freeze-dried vaccines in vials.

Authors:  M Le Meste; D Simatos; J M Préaud; P M Precausta
Journal:  J Biol Stand       Date:  1985-07

5.  Freeze drying and residual moisture.

Authors:  E B Seligmann; J F Farber
Journal:  Cryobiology       Date:  1971-04       Impact factor: 2.487

6.  The influence of methods of production, purification and storage of monoclonal antibodies upon their observed specificities.

Authors:  P A Underwood; P A Bean
Journal:  J Immunol Methods       Date:  1985-06-25       Impact factor: 2.303

7.  One-step purification of mouse monoclonal antibodies from ascitic fluid by DEAE Affi-Gel blue chromatography.

Authors:  C Bruck; D Portetelle; C Glineur; A Bollen
Journal:  J Immunol Methods       Date:  1982-09-30       Impact factor: 2.303

8.  Two-step purification of a murine monoclonal antibody intended for therapeutic application in man. Optimisation of purification conditions and scaling up.

Authors:  W Jiskoot; J J Van Hertrooij; J W Klein Gebbinck; T Van der Velden-de Groot; D J Crommelin; E C Beuvery
Journal:  J Immunol Methods       Date:  1989-11-13       Impact factor: 2.303

9.  Haemoglobin lyophilized with sucrose: the effect of residual moisture on storage.

Authors:  T I Pristoupil; M Kramlová; H Fortová; S Ulrych
Journal:  Haematologia (Budap)       Date:  1985

10.  Stabilization of phosphofructokinase with sugars during freeze-drying: characterization of enhanced protection in the presence of divalent cations.

Authors:  J F Carpenter; L M Crowe; J H Crowe
Journal:  Biochim Biophys Acta       Date:  1987-01-20
View more
  9 in total

Review 1.  Past, present, and future technologies for oral delivery of therapeutic proteins.

Authors:  Rajesh Singh; Shailesh Singh; James W Lillard
Journal:  J Pharm Sci       Date:  2008-07       Impact factor: 3.534

2.  Vacuum foam drying for preservation of LaSota virus: effect of additives.

Authors:  Sambhaji Pisal; Gopal Wawde; Shailendra Salvankar; Sanjay Lade; Shivajirao Kadam
Journal:  AAPS PharmSciTech       Date:  2006-07-21       Impact factor: 3.246

3.  Cryoprotection-lyophilization and physical stabilization of rifampicin-loaded flower-like polymeric micelles.

Authors:  Marcela A Moretton; Diego A Chiappetta; Alejandro Sosnik
Journal:  J R Soc Interface       Date:  2011-08-24       Impact factor: 4.118

4.  Decreased protein-stabilizing effects of cryoprotectants due to crystallization.

Authors:  K Izutsu; S Yoshioka; T Terao
Journal:  Pharm Res       Date:  1993-08       Impact factor: 4.200

5.  Effect of cyclodextrins on protein binding of drugs: the diflunisal/hydroxypropyl-beta-cyclodextrin model case.

Authors:  E E Sideris; M A Koupparis; P E Macheras
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

6.  Increased stabilizing effects of amphiphilic excipients on freeze-drying of lactate dehydrogenase (LDH) by dispersion into sugar matrices.

Authors:  K Izutsu; S Yoshioka; S Kojima
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

7.  Thermal resilience of ensilicated lysozyme via calorimetric and in vivo analysis.

Authors:  A Doekhie; M N Slade; L Cliff; L Weaver; R Castaing; J Paulin; Y-C Chen; K J Edler; F Koumanov; K J Marchbank; J M H van den Elsen; A Sartbaeva
Journal:  RSC Adv       Date:  2020-08-12       Impact factor: 4.036

8.  Dextranol: An inert xeroprotectant.

Authors:  Bryan J Jones; Advitiya Mahajan; Alptekin Aksan
Journal:  PLoS One       Date:  2019-09-06       Impact factor: 3.240

9.  Be Aggressive! Amorphous Excipients Enabling Single-Step Freeze-Drying of Monoclonal Antibody Formulations.

Authors:  Christina Haeuser; Pierre Goldbach; Joerg Huwyler; Wolfgang Friess; Andrea Allmendinger
Journal:  Pharmaceutics       Date:  2019-11-17       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.